SU-E-T-790: Validation of 4D Measurement-Guided Dose Reconstruction (MGDR) with OCTAVIUS 4D System

Authors

  • Lee V,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Blanck O,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Leung R,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Wong M,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Law G,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Lee K,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Tung S,

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author
  • Chan M

    1. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    2. University Clinic Schleswig-Holstein, Kiel, Kiel
    3. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    4. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    5. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    6. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    7. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    8. Tuen Mun Hospital, Hong Kong, Hong Kong (S.A.R)
    Search for more papers by this author

Abstract

Purpose:

To validate the MGDR of OCTAVIUS 4D system (PTW, Freiburg, Germany) for quality assurance (QA) of volumetric-modulated arc radiotherapy (VMAT).

Methods:

4D-MGDR measurements were divided into two parts: 1) square fields from 2×2 to 25×25 cm2 at 0°, 10° and 45° gantry, and 2) 8 VMAT plans (5 nasopharyngeal and 3 prostate) collapsed to gantry 40° in QA mode in Monaco v5.0 (Elekta, CMS, Maryland Heights, MO) were delivered on the OCTAVIUS 4D phantom with the OCTAVIUS 1500 detector plane perpendicular to either the incident beam to obtain the reconstructed dose (OCTA4D) or the 0° gantry axis to obtain the raw doses (OCTA3D) in Verisoft 6.1 (PTW, Freiburg, Germany). Raw measurements of OCTA3D were limited to < 45° gantry to avoid >0.5% variation of detector angular response with respect to 0° gantry as determined previously. Reconstructed OCTA4D and raw OCTA3D doses for all plans were compared at the same detector plane using γ criteria of 2% (local dose)/2mm and 3%/3mm criteria.

Results:

At gantry 0° and 10°, the γ results for all OCTA4D on detector plane coinciding with OCTA3D were over 90% at 2%/2mm except for the largest field (25×25 cm2 ) showing >88%. For square field at 45° gantry, γ passing rate is > 90% for fields smaller than 15x 15cm2 but < 80% for field size of 20 x20 cm2 upward. For VMAT, γ results showed 94% and 99% passing rate at 2%/2mm and 3%/3mm, respectively.

Conclusion:

OCTAVIUS 4D system has compromised accuracy in reconstructing dose away from the central beam axis, possibly due to the off-axis softening correction and errors of the percent depth dose data necessary as input for MGDR. Good results in

VMAT delivery suggested that the system is relatively reliable for VMAT with small segments.

Ancillary